sglt2 vs glp 1 Effects of Pharmacologic Therapy for Diabetes Mellitus on The Endocrine System Blood pressure effects of SGLT2

Lemme Reset contains each ingredient at its clinically studied dose: 200mg Eriomin, 400mg Morosil, and 176.5mg Supresa the same doses used in the published clinical trials

Diabetes - GLP-1 agonists should be primarily considered in patients with type 2 diabetes with suboptimal glycaemic control despite maximal tolerated dose of metformin (+/- other agents) especially where weight loss is desired and/or significant stroke risk is present

they need to be used in combination with other hypoglycemic drugs or insulin, thereby posing a risk of hypoglycemia related to the type of combined drug and dose

Patients receiving GC therapy represent a highly heterogeneous group, including individuals with SID, short-term hyperglycemia in previously normoglycemic patients initiating GC therapy, SIH in patients with T2DM and PTDM

Lost wages: Compensation often includes lost income